Your browser doesn't support javascript.
loading
Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies.
Guaman-Bautista, Linda P; Moreta-Urbano, Erick; Oña-Arias, Claudia G; Torres-Arias, Marbel; Kyriakidis, Nikolaos C; Malci, Koray; Jonguitud-Borrego, Nestor; Rios-Solis, Leonardo; Ramos-Martinez, Espiridion; López-Cortés, Andrés; Barba-Ostria, Carlos.
Affiliation
  • Guaman-Bautista LP; Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170147, Ecuador.
  • Moreta-Urbano E; Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170147, Ecuador.
  • Oña-Arias CG; Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170147, Ecuador.
  • Torres-Arias M; Immunology and Virology Laboratory, Department of Life Science and Agriculture, Universidad de las Fuerzas Armadas, Quito 171103, Ecuador.
  • Kyriakidis NC; Grupo de Investigación en Biotecnología Aplicada a Biomedicina (BIOMED), Universidad de Las Américas, Quito 170125, Ecuador.
  • Malci K; One Health Research Group, Faculty of Medicine, Universidad de Las Américas (UDLA), Quito 170125, Ecuador.
  • Jonguitud-Borrego N; Institute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh EH8 9LE, UK.
  • Rios-Solis L; Centre for Synthetic and Systems Biology (SynthSys), University of Edinburgh, Edinburgh EH8 9LE, UK.
  • Ramos-Martinez E; Institute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh EH8 9LE, UK.
  • López-Cortés A; Centre for Synthetic and Systems Biology (SynthSys), University of Edinburgh, Edinburgh EH8 9LE, UK.
  • Barba-Ostria C; Institute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh EH8 9LE, UK.
Diagnostics (Basel) ; 11(11)2021 Oct 26.
Article in En | MEDLINE | ID: mdl-34829328
The COVID-19 pandemic has had an enormous impact on economies and health systems globally, therefore a top priority is the development of increasingly better diagnostic and surveillance alternatives to slow down the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order to establish massive testing and contact tracing policies, it is crucial to have a clear view of the diagnostic options available and their principal advantages and drawbacks. Although classical molecular methods such as RT-qPCR are broadly used, diagnostic alternatives based on technologies such as LAMP, antigen, serological testing, or the application of novel technologies such as CRISPR-Cas for diagnostics, are also discussed. The present review also discusses the most important automation strategies employed to increase testing capability. Several serological-based diagnostic kits are presented, as well as novel nanotechnology-based diagnostic methods. In summary, this review provides a clear diagnostic landscape of the most relevant tools to track COVID-19.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Diagnostics (Basel) Year: 2021 Document type: Article Affiliation country: Ecuador Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Diagnostics (Basel) Year: 2021 Document type: Article Affiliation country: Ecuador Country of publication: Switzerland